Researcher in lab

Find clinical trials

Our clinical trial portfolio is one of the largest in the country. We have more than 700 clinical trials open across 30 clinical units.

Clear filter
665 clinical trials found
Clinical trials

PERFORM-CPR

Personalised Exercise Rehabilitation FOR people with multimorbidity (ACTRN12624001191583)

Many people in Australia are living with multiple long-term health conditions such as heart and lung disease, diabetes, arthritis, stroke, depression, and cancer. Exercise-based rehabilitation may help people with chronic conditions improve their physical function, symptoms and quality of life and help them spend less time in the hospital. However, until now there have been few exercise options for people living with multiple long-term health conditions. We are now conducting a study to see if a personalised rehabilitation program (PERFORM trial), which includes exercises and education sessions, can improve wellbeing and physical function better than usual care in people with multiple long-term health conditions.
Currently recruiting

Pilot SEMA-Obesity

Effects of Semaglutide on Myocardial Energetics in People with Obesity: A Pilot Prospective Mechanistic Study (Trial Not Registered)

A pilot study investigating the acute effects of semaglutide on the heart
Coming soon

PIPE-791-201

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Oral PIPE-791 in Subjects with Idiopathic Pulmonary Fibrosis (NCT07284459)

This is a Phase 2, randomized, double-blind, placebo-controlled, global multicenter study to evaluate the efficacy, safety, tolerability, and PK of PIPE-791 in subjects with a clinical diagnosis of IPF with or without background antifibrotic treatment.
Coming soon

PIPOZA

Clonal Dynamics of Chronic Lymphocytic Leukaemia Treated with Pirtobrutinib after Previous Treatment with Zanubrutinib (NCT06812715)

This is a multicentre single-arm prospective phase II trial evaluating pirtobrutinib in the treatment of relapsed/refractory (R/R) Chronic Lymphocytic Leukaemia (CLL) patients who have previously received zanubrutinib, and to specifically evaluate Bruton Tyrosine Kinase (BTK) mutational status (clonal dynamics) before, during and after treatment with pirtobrutinib.
Currently recruiting

Portico IDE

Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial (PORTICO)

The PORTICO pivotal IDE trial is a prospective, multi-center, randomized, controlled clinical investigation study designed to evaluate the safety and effectiveness of the SJM Portico Transcatheter Heart Valve and Delivery Systems (Portico) via transfemoral and alternative delivery methods in high-risk and extreme-risk patients.

No longer recruiting